
Banka Bioloo (BANKA) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
148.4M
Gross Profit
81.2M
54.73%
Operating Income
-8.3M
-5.61%
Net Income
-16.2M
-10.89%
Balance Sheet Metrics
Total Assets
821.6M
Total Liabilities
505.7M
Shareholders Equity
315.9M
Debt to Equity
1.60
Cash Flow Metrics
Revenue & Profitability Trend
Banka Bioloo Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 541.7M | 500.0M | 423.5M | 387.5M | 304.6M |
Cost of Goods Sold | 215.1M | 162.4M | 55.4M | 67.2M | 38.1M |
Gross Profit | 326.6M | 337.6M | 368.1M | 320.3M | 266.5M |
Gross Margin % | 60.3% | 67.5% | 86.9% | 82.7% | 87.5% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 22.5M | 19.5M | 17.5M | 17.0M |
Other Operating Expenses | 63.9M | 34.6M | 47.5M | 65.7M | 76.6M |
Total Operating Expenses | 63.9M | 57.1M | 67.0M | 83.3M | 93.6M |
Operating Income | -54.0M | 17.4M | 47.1M | 46.2M | 28.5M |
Operating Margin % | -10.0% | 3.5% | 11.1% | 11.9% | 9.4% |
Non-Operating Items | |||||
Interest Income | - | 3.8M | 5.6M | 3.9M | 4.8M |
Interest Expense | 37.6M | 23.9M | 15.0M | 16.4M | 14.7M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -91.2M | -5.6M | 36.2M | 33.1M | 18.7M |
Income Tax | -2.2M | 1.1M | 10.9M | 2.0M | -3.4M |
Effective Tax Rate % | 0.0% | 0.0% | 29.9% | 6.1% | -18.0% |
Net Income | -89.1M | -6.7M | 25.4M | 31.1M | 22.0M |
Net Margin % | -16.4% | -1.3% | 6.0% | 8.0% | 7.2% |
Key Metrics | |||||
EBITDA | -25.2M | 40.2M | 66.1M | 58.9M | 39.2M |
EPS (Basic) | - | ₹-0.60 | ₹2.34 | ₹3.02 | ₹2.14 |
EPS (Diluted) | - | ₹-0.60 | ₹2.34 | ₹3.02 | ₹2.14 |
Basic Shares Outstanding | - | 10800000 | 10800000 | 10300000 | 10281120 |
Diluted Shares Outstanding | - | 10800000 | 10800000 | 10300000 | 10281120 |
Income Statement Trend
Banka Bioloo Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 2.5M | 3.1M | 8.4M | 3.2M | 18.1M |
Short-term Investments | 140.6M | 40.7M | 5.0M | 5.1M | 25.2M |
Accounts Receivable | 278.0M | 229.6M | 229.3M | 203.6M | 116.8M |
Inventory | 58.2M | 82.6M | 87.2M | 83.9M | 80.3M |
Other Current Assets | 32.7M | 1.0K | -1.0K | 3.0M | 2.5M |
Total Current Assets | 532.4M | 493.4M | 414.8M | 475.6M | 360.1M |
Non-Current Assets | |||||
Property, Plant & Equipment | 157.7M | 140.5M | 88.0M | 31.0M | 22.1M |
Goodwill | 905.0K | 7.4M | 7.3M | 7.3M | 1.2M |
Intangible Assets | 905.0K | 1.1M | 982.0K | 1.0M | 1.2M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | 1.0K | 55.6M | 50.2M | 1.4M |
Total Non-Current Assets | 289.1M | 280.8M | 237.2M | 165.0M | 103.6M |
Total Assets | 821.6M | 774.2M | 652.1M | 640.5M | 463.7M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 54.5M | 39.3M | 31.5M | 36.6M | 24.9M |
Short-term Debt | 230.6M | 145.3M | 106.5M | 93.9M | 48.8M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 78.6M | 9.6M | 29.3M | 11.8M | 3.4M |
Total Current Liabilities | 378.9M | 253.5M | 184.0M | 171.5M | 91.9M |
Non-Current Liabilities | |||||
Long-term Debt | 116.7M | 113.9M | 60.7M | 91.1M | 68.2M |
Deferred Tax Liabilities | 2.1M | 3.6M | 2.2M | 0 | 0 |
Other Non-Current Liabilities | - | 15.0K | -36.0K | -2.0K | 98 |
Total Non-Current Liabilities | 126.8M | 123.1M | 67.1M | 94.0M | 71.5M |
Total Liabilities | 505.7M | 376.6M | 251.1M | 265.5M | 163.4M |
Equity | |||||
Common Stock | 108.7M | 108.5M | 108.5M | 108.5M | 102.8M |
Retained Earnings | - | 203.6M | 207.4M | 179.6M | 148.6M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 315.9M | 397.6M | 401.0M | 375.0M | 300.3M |
Key Metrics | |||||
Total Debt | 347.3M | 259.1M | 167.2M | 185.0M | 117.0M |
Working Capital | 153.5M | 239.9M | 230.8M | 304.1M | 268.1M |
Balance Sheet Composition
Banka Bioloo Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -91.2M | -5.6M | 36.2M | 33.1M | 18.7M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 22.0M | -13.6M | 26.8M | -53.9M | 44.4M |
Operating Cash Flow | -34.9M | 617.0K | 71.6M | -7.9M | 73.5M |
Investing Activities | |||||
Capital Expenditures | -44.4M | -99.7M | -64.1M | -31.6M | -5.1M |
Acquisitions | -20.0K | - | - | - | - |
Investment Purchases | - | - | - | -168.2K | -232.7K |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -44.5M | -99.7M | -64.1M | -31.7M | -5.3M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | -4.1M |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | 276.0K | 38.3M | 11.7M | 26.7M | -5.2M |
Free Cash Flow | -36.1M | -72.1M | 9.4M | -36.0M | 53.5M |
Net Change in Cash | -79.1M | -60.8M | 19.2M | -12.9M | 63.0M |
Cash Flow Trend
Banka Bioloo Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
57.14
Price to Book
3.04
Price to Sales
1.78
Profitability Ratios
Profit Margin
-16.44%
Operating Margin
-5.61%
Return on Equity
-24.97%
Return on Assets
-4.23%
Financial Health
Current Ratio
1.40
Debt to Equity
109.95
Beta
0.54
Per Share Data
EPS (TTM)
₹-8.21
Book Value per Share
₹29.26
Revenue per Share
₹49.93
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
banka | 965.9M | 57.14 | 3.04 | -24.97% | -16.44% | 109.95 |
Ion Exchange (India | 53.6B | 24.37 | 4.71 | 20.38% | 7.69% | 0.20 |
Filtra Consultants | 718.1M | 22.82 | 2.74 | 12.17% | 3.35% | 0.00 |
Quality RO | 343.0M | 19.87 | 3.01 | 16.28% | 10.79% | 55.49 |
Larsen & Toubro | 5.0T | 31.27 | 5.08 | 13.03% | 5.90% | 114.74 |
Hindustan | 3.4T | 36.36 | 8.70 | 26.09% | 27.00% | 0.00 |
Financial data is updated regularly. All figures are in the company's reporting currency.